Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | CNR1 | P21554 | 3/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15936325 | 0.88 | ALDH1A1 (0.50) | HSD17B10ALDH1A1LMNAGAANPC1 | |
| SCHEMBL8337431 | 0.87 | CA1 (0.58) | HSD17B10CA1CA2CA5ACA9 | |
| SCHEMBL1990490 | 0.82 | ALDH1A1 (0.61) | ALDH1A1GAAPOLBCNR1 | |
| SCHEMBL14477864 | 0.82 | POLB (0.53) | HSD17B10CA1CA2CA5ACA9 | |
| SCHEMBL1256021 | 0.81 | CNR1 (0.51) | ALDH1A1LMNAGAANPC1POLB | |
| SCHEMBL1987895 | 0.81 | CNR1 (0.54) | ALDH1A1LMNAGAANPC1POLB | |
| SCHEMBL29467287 | 0.81 | CNR1 (0.51) | ALDH1A1LMNAGAANPC1POLB | |
| SCHEMBL14696892 | 0.81 | CA1 (0.55) | CA1CA2CA9ALDH1A1LMNA | |
| SCHEMBL7080602 | 0.80 | MAPT (0.65) | HSD17B10ALDH1A1LMNAPOLB | |
| SCHEMBL17502107 | 0.78 | KMT2A (0.65) | ALDH1A1LMNAGAACNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2744330-B1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS | UNIV UTAH RES FOUND (US) | 2020-07-15 | — | — | EP | disclosed |
| CN-110015984-A | Substituted (E)-N '-(1- phenylethylene) benzoyl hydrazine analog as histone demethylase inhibitor | 犹他大学研究基金会 | 2019-07-16 | — | — | CN | disclosed |
| EP-3010915-B1 | SUBSTITUTED (3-(5-CHLORO-2-HYDROXYPHENYL)-1-BENZOYL-1H-PYRAZOLE COMPOUNDS AS HISTONE DEMETHYLASE INHIBITORS | UNIV UTAH RES FOUND (US) | 2019-05-08 | — | — | EP | disclosed |
| CN-105555784-B | Substituted (E) -N' - (1-phenylethylene) benzoyl hydrazine analogs as histone demethylase inhibitors | 犹他大学研究基金会 | 2019-03-15 | — | — | CN | disclosed |
| US-9642857-B2 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2017-05-09 | — | — | US | disclosed |
| US-9555024-B2 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2017-01-31 | — | — | US | disclosed |
| US-20160120875-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | UNIV UTAH RES FOUND (US) | 2016-05-05 | — | — | US | disclosed |
| EP-3010915-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | University of Utah Research Foundation (US) | 2016-04-27 | — | — | EP | disclosed |
| US-9266838-B2 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2016-02-23 | — | — | US | disclosed |
| US-20150150864-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2015-06-04 | — | — | US | disclosed |
| US-8987335-B2 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2015-03-24 | — | — | US | disclosed |
| WO-2014205213-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2014-12-24 | — | — | WO | disclosed |
| CN-103929960-A | Substituted -N' - (1-phenylethylidene) benzoyl hydrazine analogs as histone demethylase inhibitors | UNIV UTAH RES FOUND | 2014-07-16 | — | — | CN | disclosed |
| EP-2744330-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS | University Of Utah Research Foundation (US) | 2014-06-25 | — | — | EP | disclosed |
| US-20140163017-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | UNIVERSITY OF UTAH (US) | 2014-06-12 | — | — | US | disclosed |
| WO-2013025805-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE) BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIITORS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150150864-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | KDM1B, KDM1A, DOT1L | HSD17B10 984/4885CA1 2649/4885CA2 2622/4885 |
| US-20140163017-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | KDM1B, KDM1A, DOT1L | HSD17B10 984/4885CA1 2649/4885CA2 2622/4885 |
| US-20160120875-A1 | SUBSTITUTED (E)-N'-(1-PHENYLETHYLIDENE)BENZOHYDRAZIDE ANALOGS AS HISTONE DEMETHYLASE INHIBITORS | DOT1L, NSD1, KDM1B | HSD17B10 1481/4885CA1 4143/4885CA2 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.